StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
4025.T$4840.00-2.81%
Fair $4840.00+0.0%

4025.T

Taki Chemical Co., Ltd.

Basic Materials / ChemicalsTokyo

$4840.00

-140.00 (-2.81%)

Fairly Valued+0.0%Fair Value $4840.00Fund rank 35/100 · Data gapFallback financials|
SA 67/B
F-Score: 5/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 24% · confianza 25%

FCF escenarios

weak_data · normalized FCF $2.3B · quality 73.0/100

Data gap 35/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 65/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

67/100

B

Piotroski

5/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Sector-specific commodity mid-cycle model required: targets are disabled until normalized cycle price/cost-curve/reserve data exists.
Thesis & Journal · 4025.TLocal privado en este navegador · Taki Chemical Co., Ltd.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$40.4B

P/E

12.4x

↓

EV/EBITDA

6.0x

↓

ROE

7.6%

↑

Gross Margin

24.4%

↑

Debt/Equity

0.03

↓
52-Week Range$4840
$2804$5610

TradingView lightweight chart

4025.T price, volumen y niveles de valoración

Último $4,840Periodo +423.2%
Fair value: $4,840

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+5.4%

FCF CAGR

+17.0%

FCF margin

5.5%

FCF / Net income

0.70x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $41.98B · net income $3.28B · FCF $2.31B

2022-FY → 2025-FY

Gross margin

24.4%-0.2% pts

Operating margin

7.5%-0.1% pts

Net margin

7.8%+2.1% pts

FCF margin

5.5%+1.5% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$41.98B$41.98B$38.92B$34.85B$35.85B
Net Income$3.28B$3.28B$2.30B$1.36B$2.06B
EBITDA$5.76B$5.76B$4.52B$3.11B$4.33B
EPS——271.37156.86237.53
Gross Margin24.4%24.4%23.1%19.9%24.6%
Operating Margin7.5%7.5%6.9%2.6%7.7%
Net Margin7.8%7.8%5.9%3.9%5.7%
Balance Sheet
Debt/Equity0.030.030.030.030.04
Current Ratio2.712.71———
Cash Flow
Free Cash Flow$2.31B$2.31B$4.34B$1.62B$1.44B
Returns
ROE7.6%7.6%6.1%4.0%6.4%
Valuation
P/E12.4412.4412.7120.0818.63
EV/EBITDA5.985.985.097.497.69
P/B0.940.940.770.811.20
Growth & Yield
Revenue Growth7.9%7.9%11.7%-2.8%—
EPS Growth——73.0%-34.0%—
Dividend Yield1.6%1.6%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +67.6%

Total return

+67.6%

Start / end P/E

n/dx → n/dx

EPS bridge

271.37 → n/d

Residual

+66.0%

EPS growthn/d
Multiple reratingn/d
Dividend+1.6%
Residual / FX / buybacks / cross-term+66.0%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.